We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Obese Children Require Less General Anesthesia

By HospiMedica International staff writers
Posted on 02 Nov 2011
Obese children require smaller doses of the general anesthetic (GA) propofol than non-obese children do to bring about a safe level of unconsciousness, according to a new study.

Researchers at the Texas Children's Hospital (Houston, USA) conducted a study involving 40 obese and 40 non-obese children using a process called the biased coin design, which requires fewer patients and provides a more accurate calculation of dose requirements than older techniques. More...
After measuring each child's response 20 seconds after receiving propofol, it was determined that obese children needed 2 mg/kg of propofol to bring about unconsciousness at the beginning of surgery, compared to normal weight children who needed 50% to 60% more propofol (3.2 mg/kg).

The researchers explained that since propofol can cause prolonged sleepiness and decreased breathing, it is important for anesthesiologists to consider whether the anesthetic drug dose delivered should be based on the child's actual weight or on his lean body weight. In obese children, 75% of excess body weight consists of fat tissue, which alters drug distribution. The study was presented at the American Society of Anesthesiologists (ASA) annual Anesthesiology meeting, held during October 2011 in Chicago (IL, USA).

“These study findings mean that when providing care for obese children with propofol, 95% of children will likely need only a smaller dose of propofol to initiate anesthesia for surgical procedures,” said lead author and study presenter Olutoyin Olutoye, MD, MSc. “This is important as propofol may cause low blood pressure, an effect that can be worsened if larger-than-needed amounts are given.”

Propofol is a short-acting, intravenously administered hypnotic agent. Its uses include the induction and maintenance of GA, sedation for mechanically ventilated adults, and procedural sedation. Propofol is unrelated to barbiturates and it has largely replaced sodium thiopental (Pentothal) for induction of anesthesia since recovery from propofol is more rapid and unambiguous when compared with sodium thiopental.

Related Links:
Texas Children's Hospital



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.